{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:15:58Z","timestamp":1770070558725,"version":"3.49.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,4]]},"DOI":"10.1016\/s0008-6363(97)00324-6","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T22:52:50Z","timestamp":1027637570000},"page":"198-205","source":"Crossref","is-referenced-by-count":52,"title":["Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte"],"prefix":"10.1093","volume":"38","author":[{"given":"Atsuo","family":"Tahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Tomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koh-ichi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Kusayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noe","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeyuki","family":"Yatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1998,4]]},"reference":[{"key":"key\n\t\t\t\t20170624081958_bib1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00004872-198512000-00001","article-title":"Vasopressin in circulatory control and hypertension","volume":"3","author":"Johnston","year":"1985","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20170624081958_bib2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00004872-198908000-00001","article-title":"Salt-induced hypertension: the interactive role of vasopressin and of the sympathetic nervous system","volume":"7","author":"Gavras","year":"1989","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t20170624081958_bib3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1161\/01.RES.73.3.439","article-title":"Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy","volume":"73","author":"Suzuki","year":"1993","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20170624081958_bib4","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0006-291X(89)80165-2","article-title":"Specific receptor for endothelin in cultured rat cardiomyocytes","volume":"160","author":"Hirata","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20170624081958_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.RES.69.1.239","article-title":"Vasopressin increases cytosolic free [Ca2+] in the neonatal rat cardiomyocyte","volume":"69","author":"Xu","year":"1991","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20170624081958_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1042\/bst0070861","article-title":"Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin","volume":"7","author":"Michell","year":"1979","journal-title":"Biochem Soc Trans"},{"key":"key\n\t\t\t\t20170624081958_bib7","first-page":"H597","article-title":"[Ca2+]i and protein kinase C in vasopressin-induced prostacyclin and ANP release in rat cardiomyocytes","volume":"266","author":"Van der Bent","year":"1994","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t20170624081958_bib8","first-page":"H261","article-title":"Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors","volume":"255","author":"Walker","year":"1988","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t20170624081958_bib9","first-page":"73","article-title":"Pharmacology and clinical perspectives of vasopressin antagonists","volume":"43","author":"Laszlo","year":"1991","journal-title":"Pharmacol Rev"},{"key":"key\n\t\t\t\t20170624081958_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0166-2236(84)80179-4","article-title":"Design and uses of selective agonistic and antagonistic analogs of the neuropeptides oxytocin and vasopressin","volume":"7","author":"Manning","year":"1984","journal-title":"Trends Neurosci"},{"key":"key\n\t\t\t\t20170624081958_bib11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.1850553","article-title":"OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist","volume":"252","author":"Yamamura","year":"1991","journal-title":"Science"},{"key":"key\n\t\t\t\t20170624081958_bib12","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/0024-3205(92)90524-S","article-title":"Radioligand binding studies reveal marked species differences in the vasopressin V1 receptor of rat, rhesus and human tissues","volume":"50","author":"Pettibone","year":"1992","journal-title":"Life Sci"},{"key":"key\n\t\t\t\t20170624081958_bib13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1476-5381.1992.tb09058.x","article-title":"Characterization of a novel aquaretic agent, OPC-31260, as an orally effective, nonpeptide vasopressin V2 receptor antagonist","volume":"105","author":"Yamamura","year":"1992","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170624081958_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI116554","article-title":"Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors","volume":"92","author":"Serradeil-Le Gal","year":"1993","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170624081958_bib15","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1172\/JCI119098","article-title":"Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist","volume":"98","author":"Serradeil-Le Gal","year":"1996","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170624081958_bib16","first-page":"S15","article-title":"Effects of an oral, nonpeptide, selective V2 receptor AVP antagonist in human heart failure","volume":"3","author":"Abraham","year":"1997","journal-title":"Nephrology"},{"key":"key\n\t\t\t\t20170624081958_bib17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0006-291X(91)90165-4","article-title":"Effect of a new V1 antagonist (OPC-21268) on vascular action of vasopressin in cultured rat vascular smooth muscle cells","volume":"178","author":"Okada","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20170624081958_bib18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/01.HYP.23.2.217","article-title":"Inhibition of vasopressin action in vascular smooth muscle by the V1 antagonist OPC-21268","volume":"23","author":"Li","year":"1994","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170624081958_bib19","first-page":"H404","article-title":"Effect of SR-49059, a vasopressin V1a antagonist, on human vascular smooth muscle cells","volume":"268","author":"Serradeil-Le Gal","year":"1995","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t20170624081958_bib20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0006-2952(94)90125-2","article-title":"Effect of a new, potent, non-peptide V1a vasopressin antagonist, SR 49059, on the binding and the mitogenic activity of vasopressin on Swiss 3T3 cells","volume":"47","author":"Serradeil-Le Gal","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t20170624081958_bib21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/01.HYP.19.6.730","article-title":"Effects of a nonpeptide vasopressin antagonist (OPC-21268) on cytosolic Ca2+ concentration in vascular and cardiac myocytes","volume":"19","author":"Matsui","year":"1992","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20170624081958_bib22","first-page":"S177","article-title":"Functional characterization of vasopressin V1 and V2 receptors in the rabbit renal cortical collecting duct","volume":"55","author":"Yoshitomi","year":"1996","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170624081958_bib23","first-page":"301","article-title":"Pharmacological profile of YM087, a novel potent nonpeptide vasopressin V1A and V2 receptor antagonist, in vitro and in vivo","volume":"282","author":"Tahara","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"key\n\t\t\t\t20170624081958_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0014-2999(96)00940-5","article-title":"Pharmacological profile of YM087, a novel nonpeptide dual vasopressin V1A and V2 receptor antagonist, in dogs","volume":"321","author":"Yatsu","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"key\n\t\t\t\t20170624081958_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1161\/01.RES.50.1.101","article-title":"Differentiation of rat myocytes in single cell cultures with and without proliferating nonmyocardial cells","volume":"50","author":"Simpson","year":"1982","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20170624081958_bib26","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1073\/pnas.87.11.4275","article-title":"Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro","volume":"87","author":"Ito","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170624081958_bib27","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t20170624081958_bib28","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","article-title":"A new generation of Ca2+ indicators with greatly improved fluorescence properties","volume":"260","author":"Grynkiewicz","year":"1985","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170624081958_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10799898909066041","article-title":"Direct identification of the rat hepatocyte arginine8 vasopressin receptor with a radiolabelled V1-selective antagonist","volume":"9","author":"Cornett","year":"1989","journal-title":"J Recept Res"},{"key":"key\n\t\t\t\t20170624081958_bib30","first-page":"H1927","article-title":"Vasopressin (V1) receptor characteristics in rat aortic smooth muscle cells","volume":"261","author":"Gopalakrishnan","year":"1991","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t20170624081958_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-0115(92)90067-5","article-title":"Signal transduction of V1-vascular vasopressin receptors","volume":"38","author":"Thibonnier","year":"1992","journal-title":"Regul Pept"},{"key":"key\n\t\t\t\t20170624081958_bib32","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1006\/bbrc.1993.1687","article-title":"Distinct mechanisms of action of V1 antagonists OPC-21268 and [d(CH2)5Tyr(Me)AVP] in mesangial cells","volume":"193","author":"Jamil","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20170624081958_bib33","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI116579","article-title":"Endothelin-1 is an autocrine\/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes","volume":"92","author":"Ito","year":"1993","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170624081958_bib34","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1073\/pnas.89.4.1305","article-title":"Transcriptional activation of the cardiac myosin light chain 2 and atrial natriuretic factor genes by protein kinase C in neonatal rat ventricular myocytes","volume":"89","author":"Shubeita","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170624081958_bib35","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1016\/S0021-9258(18)99178-7","article-title":"Expression of a constitutively activated mutant of the beta-isozyme of protein kinase C in cardiac myocytes stimulates the promoter of the beta-myosin heavy chain isogene","volume":"266","author":"Kariya","year":"1991","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170624081958_bib36","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/0006-291X(90)92358-7","article-title":"Vasopressin dependent tyrosine phosphorylation of a 38 kDa protein in human platelets","volume":"168","author":"Granot","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20170624081958_bib37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0968-0004(00)80005-5","article-title":"Mitogen-activated protein kinases: versatile transducers for cell signaling","volume":"17","author":"Pelech","year":"1992","journal-title":"Trends Biochem Sci"},{"key":"key\n\t\t\t\t20170624081958_bib38","doi-asserted-by":"crossref","first-page":"9564","DOI":"10.1016\/S0021-9258(18)98388-2","article-title":"Direct evidence for tyrosine and threonine phosphorylation and activation of mitogen-activated protein kinase by vasopressin in cultured rat vascular smooth muscle cells","volume":"268","author":"Granot","year":"1993","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170624081958_bib39","first-page":"G321","article-title":"Vasopressin modulates liver regeneration in the Brattleboro rat","volume":"245","author":"Russel","year":"1983","journal-title":"Am J Physiol"},{"key":"key\n\t\t\t\t20170624081958_bib40","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1073\/pnas.76.3.1284","article-title":"Vasopressin stimulation of mouse 3T3 cell growth","volume":"76","author":"Rozengurt","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170624081958_bib41","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ki.1990.276","article-title":"Arginine vasopressin gene expression in chronic cardiac failure in rats","volume":"38","author":"Kim","year":"1990","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20170624081958_bib42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1056\/NEJM198107303050506","article-title":"Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure","volume":"305","author":"Szatalowicz","year":"1981","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170624081958_bib43","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0735-1097(86)80417-X","article-title":"Hemodynamic effects of infused arginine vasopressin in congestive heart failure","volume":"8","author":"Goldsmith","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20170624081958_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/cvr\/25.1.68","article-title":"Vasopressin and angiotensin II contribute equally to the increased afterload in rabbits with heart failure","volume":"25","author":"Arnolda","year":"1991","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20170624081958_bib45","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0002-9149(85)90743-X","article-title":"Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure","volume":"55","author":"Nicod","year":"1985","journal-title":"Am J Cardiol"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/38\/1\/198\/17875847\/38-1-198.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T20:26:13Z","timestamp":1620851173000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-lookup\/doi\/10.1016\/S0008-6363(97)00324-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1998,4]]},"published-print":{"date-parts":[[1998,4]]}},"URL":"https:\/\/doi.org\/10.1016\/s0008-6363(97)00324-6","relation":{},"ISSN":["1755-3245","0008-6363"],"issn-type":[{"value":"1755-3245","type":"electronic"},{"value":"0008-6363","type":"print"}],"subject":[],"published":{"date-parts":[[1998,4]]}}}